We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 195

Is the Groundwork Being Laid for New Federal Cannabis Regulation?
  • Venable LLP
  • USA
  • July 5 2018

The U.S. Food and Drug Administration's (FDA) recent approval of Epidiolex may one day be looked at as a watershed moment in the history of marijuana


FTC and House Start Working Together to Address CPSC-related Connected Technology Issues - Stakeholders Should Prepare for Future Government-Wide Cooperation
  • Venable LLP
  • USA
  • June 19 2018

Robust conversations about IoT, smart technology, and product safety continue across the federal government. On May 16, 2018, the Consumer Product


The Internet of Things, Product Safety, and Product Liability: A Risky Combination
  • Venable LLP
  • USA
  • May 23 2018

On May 16, 2018, the Consumer Product Safety Commission held a public hearing to receive testimony on the Internet of Things (IoT) and issues related


Is Past Prologue for FTC Jurisdiction?
  • Venable LLP
  • USA
  • March 29 2018

A recent decision in an antitrust case brought by the FTC in the U.S. District Court for Delaware could significantly limit the FTC’s ability to bring


"Off-label" Cases Aren't Going Away - DOJ Sheds Light on Direction of Enforcement of Misbranding Rules Governing Medical Products
  • Venable LLP
  • USA
  • March 6 2018

On February 28, Ethan Davis, the U.S. Department of Justice's (DOJ) deputy assistant attorney general responsible for consumer protection, gave a


FDA, CPSC & the Need for Speed: Recent Actions Highlight Importance of Promptly Reporting Product Safety Issues
  • Venable LLP
  • USA
  • February 7 2018

On consecutive days last month, both the Consumer Product Safety Commission (CPSC) and the U.S. Food and Drug Administration (FDA) made clear that


FDA Harshes the Vibe of CBD Makers, Warns Them to Stop Making Drug Claims
  • Venable LLP
  • USA
  • December 14 2017

While there are many questions surrounding the regulation of marijuana and related products, the FDA has made it clear where it stands on at least one


FDA Actions Smooth Pathway to Market for Genetic Health Risk Tests and Vitamin D Tests
  • Venable LLP
  • USA
  • November 13 2017

On November 6, 2017, the U.S. Food and Drug Administration (FDA or the Agency) announced a series of actions it is taking with regard to certain in


Will FDA Be Forced To Eat Menu Labeling?
  • Venable LLP
  • USA
  • November 9 2017

The Affordable Care Act (ACA) gave our nation "Obamacare." The ACA also gave the FDA the obligation to adopt regulations requiring "a restaurant or


Healthy No More? Authorized Soy Protein and Heart Disease Health Claim on FDA's Chopping Block
  • Venable LLP
  • USA
  • November 2 2017

On October 31, 2017, the U.S. Food and Drug Administration (FDA or the Agency) announced a proposal to revoke the regulation authorizing the use of a